For anyone looking to build a career in biopharma manufacturing ... Diya Abdeljabbar, director of technical operations at Merck’s vaccine manufacturing center in Durham, said the top attribute he’s ...

Unveiling of the new factory comes as Merck and other pharma companies face pressure to reshore manufacturing back to the U.S ...

A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...

Shares in pharmaceuticals giant Merck (MRK) weakened today on fears that a patent battle could jeopardize its plans to sell a ...

Vanotech Ltd, a pharmaceutical company devoted to greatly improving the lives of people living with Ophthalmic, central nervous, digestive and endocrine conditions using innovative science that ...

Radiance Biopharma is heating up the ROR1 race ... antibody-drug conjugate (ADC), securing itself a shot at challenging Merck & Co. for the opportunity. Merck is setting the pace in the ROR1 ...

Both Merck & Co. and Halozyme are holding their ... FDA approval for subcutaneous version Halozyme made a name in the biopharma world with Enhanze, which has been used in multiple products.

Patient centricity is a priority for Merck and its Executive Vice President and Head of EMEA Region for Merck Biopharma Global Commercial Operations, Chris Round, outlines what practical steps the ...